Spyre Therapeutics (SYRE) Interest & Investment Income (2015 - 2026)
Spyre Therapeutics (SYRE) reported Interest & Investment Income of $10.05 million for Q2 2026, up 71.1% from $5.87 million a year earlier and up 43.7% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Interest & Investment Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Spyre Therapeutics' Interest & Investment Income came in at $29.57 million, up 26.7% year-over-year; for FY2025, it was $24.89 million, up 16.8% from FY2024.
- Interest & Investment Income has increased for four consecutive years, with a five-year compound annual growth rate of 111.1% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $21.31 million in FY2024 (+246.7%), $6.15 million in FY2023 (+634.4%), $837,000 in FY2022 (+654.1%) and $111,000 in FY2021 (-81.3%).
- The Q2 2026 figure ranks as the highest quarterly Interest & Investment Income in data going back to Q1 2015.
- Year over year, Interest & Investment Income has now increased in each of the last four quarters, with growth averaging 63.3% over the last eight quarters.
- The high point for year-over-year Interest & Investment Income in five years was Q1 2024 (growth of 955.2%); the low point was Q3 2021 (a decline of 59.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7 million (Q1 2026), $7.14 million (Q4 2025) and $5.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Spyre Therapeutics | 8.21 Bn | 8.21 Bn | - | 10.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.05 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.14 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 5.78 Mn |
| Sep 30, 2024 | 5.18 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 350,000.00 |
| Mar 31, 2023 | 420,000.00 |
| Dec 31, 2022 | 410,000.00 |
| Sep 30, 2022 | 288,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 36,000.00 |
API Access
Spyre Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();